Want to see IN:MOREPENLAB full AI Analyst Report?
Morepen Laboratories Limited (MOREPENLAB) Income Statement
Morepen Laboratories Limited Income Statement
Last quarter (Q1 2027), Morepen Laboratories Limited's total revenue was $5.70B, an increase of 34.07% from the same quarter last year. In Q1, Morepen Laboratories Limited's net income was $563.99M. See Morepen Laboratories Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 18.06B | $ 18.30B | $ 17.02B | $ 14.18B | $ 15.42B | |
| $ 6.82B | $ 6.30B | $ 6.18B | $ 2.19B | $ 4.81B | |
| $ 5.93B | $ 3.14B | $ 1.99B | $ 4.10B | $ 1.40B | |
| Depreciation and Amortization | $ 364.35M | $ 289.82M | $ 334.69M | $ 279.30M | $ 276.43M |
| $ 1.73B | $ 1.92B | $ 1.73B | $ 856.66M | $ 1.57B | |
| $ 891.94M | $ 3.16B | $ 4.17B | $ 484.61M | $ 1.26B | |
| $ 307.26M | $ -1.61B | $ -2.82B | $ 72.94M | $ 11.61M | |
| $ 1.20B | $ 1.55B | $ 1.35B | $ 557.55M | $ 1.27B | |
| $ 948.77M | $ 1.18B | $ 961.60M | $ 386.75M | $ 1.02B | |
| Per Share Metrics | |||||
| Basic EPS | $ 1.73 | $ 2.20 | $ 1.88 | $ 0.77 | $ 2.26 |
| Diluted EPS | $ 1.73 | $ 2.20 | $ 1.88 | $ 0.77 | $ 1.96 |
| Weighted Average Shares Outstanding | 548.42M | 536.46M | 511.17M | 502.21M | 449.98M |
| Weighted Average Shares Outstanding (Diluted) | 548.42M | 536.46M | 511.17M | 502.21M | 519.83M |
Currency in INR
